Press "Enter" to skip to content

New patent expiration for Alnylam Pharms drug GIVLAARI

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Alnylam Pharms drug GIVLAARI

Annual Drug Patent Expirations for GIVLAARI
Annual Drug Patent Expirations for GIVLAARI

Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug.

This drug has three hundred and seventy-five patent family members in forty countries.

The generic ingredient in GIVLAARI is givosiran sodium. Additional details are available on the givosiran sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Alnylam Pharms drug GIVLAARI
    DrugPatentWatch - Make Better Decisions